4//SEC Filing
Arbutus Biopharma Corp 4
Accession 0001140361-16-058182
$ABUSCIK 0001447028operating
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 2:35 PM ET
Size
19.9 KB
Accession
0001140361-16-058182
Insider Transaction Report
Form 4
Kowalski Mark
Sr VP & Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-03-15+85,000→ 85,000 totalExercise: $3.94Exp: 2026-03-15→ Common Shares (85,000 underlying)
Footnotes (1)
- [F1]The options vest as follows: 1/3 on March 15, 2017; 1/3 on March 15, 2018; and 1/3 on March 15, 2019.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001447028
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 2:35 PM ET
- Size
- 19.9 KB